$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Other Current Assets
$53.00M
Quarterly · Period ending: · USD

RARE Other Current Assets
Latest reported$47.00Mperiod ending
Latest reported$47.00Mperiod ending
RARE FY Other Current Assets ($205.00K → $47.00M)
Annual other current assets
High-resolution chart · PNG
What is other current assets?
Current assets not classified elsewhere.
RARE other current assets history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Current Assets (USD) |
|---|---|
| 47,000,000 | |
| 40,290,000 | |
| 47,616,000 | |
| 68,926,000 | |
| 55,745,000 | |
| 57,630,000 | |
| 51,397,000 | |
| 42,858,000 | |
| 29,161,000 | |
| 21,547,000 | |
| 13,210,000 | |
| 11,858,000 | |
| 1,848,000 | |
| 255,000 | |
| 205,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance